Medicare Enrolled

Dr. Rajesh Desai, MD

Endocrinology · Melbourne, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2290 W EAU GALLIE BLVD, Melbourne, FL 32935
3213099000
In practice since 2005 (20 years)
NPI: 1427057256 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Desai

Dr. Rajesh Desai is an endocrinology in Melbourne, FL, with 20 years in practice. Based on federal Medicare data, Dr. Desai performed 52,522 Medicare services across 27,967 unique beneficiaries.

Between the years covered by Open Payments, Dr. Desai received a total of $9,211 from 57 pharmaceutical and/or device companies across 550 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 1% volume in FL$ $9,211 industry payments

Medicare Practice Summary

Medicare Utilization ↗
52,522
Medicare services
Top 1% in FL for endocrinology
27,967
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,626 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Blood draw (venipuncture)5,520$8$15
Comprehensive metabolic blood panel5,209$10$37
Denosumab injection (Prolia/Xgeva)4,800$18$41
Lipid panel (cholesterol and triglycerides)3,936$13$46
Complete blood count (CBC) with differential3,523$8$27
Thyroid stimulating hormone (TSH) test3,350$16$58
Hemoglobin A1c test (diabetes monitoring)3,124$9$34
Free thyroxine (T4) test2,144$9$31
Ldl cholesterol level1,630$10$33
Vitamin B-12 level test1,374$15$52
Office visit, established patient (30-39 min)1,314$92$270
Vitamin D level test1,253$29$102
CT scan of chest, without contrast1,197$49$131
Complete blood count (CBC), automated889$6$23
Urinalysis with microscopic exam862$3$11
Urine microalbumin test (kidney screening)849$6$7
Creatinine test (kidney function)816$5$18
Automated urinalysis793$2$8
Chest X-ray, 2 views759$12$34
Thyroxine (thyroid chemical), total669$7$24
Folic acid level test571$14$51
Iron level test504$6$23
Iron binding capacity test482$9$30
Ferritin level test (iron stores)448$13$47
Ultrasound scan of head and neck soft tissue380$39$115
Parathyroid hormone level test373$40$142
Creatine kinase (cardiac enzyme) level, total349$6$23
PSA test (prostate cancer screening)330$18$64
Thyroid hormone evaluation330$6$23
Prostate cancer screening; prostate specific antigen test (psa)295$19$64
C-peptide (protein) level276$20$66
Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment239$50$137
Ct scan of abdomen and pelvis without contrast209$68$166
Basic metabolic blood panel198$8$29
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report175$27$112
Complete ultrasound scan of abdomen172$41$115
Uric acid level test163$4$16
X-ray of lower and sacral spine, 2-3 views158$13$41
CT scan of head/brain, without contrast152$39$103
Low dose ct scan of chest for lung cancer screening151$66$138
Hip X-ray, 2-3 views140$17$52
C-reactive protein test (inflammation marker)138$5$18
X-ray of hand, minimum of 3 views117$14$45
Shoulder X-ray, 2+ views98$11$37
Knee X-ray, 3 views97$14$47
New patient office visit (45-59 min)91$121$415
Thyroid hormone, t3 measurement, free86$17$54
Ct scan of face without contrast85$47$138
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous79$18$55
Bilirubin level, direct76$5$18
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle75$56$129
Sed rate test (inflammation marker)70$3$10
Ultrasound study of one arm or leg veins with compression and maneuvers65$45$131
Complete ultrasound scan behind abdominal cavity64$39$161
Foot X-ray, 3+ views54$12$39
Magnesium level test51$7$23
Creatinine clearance measurement to test for kidney function50$9$33
X-ray of upper spine, 2-3 views49$12$40
X-ray of knee, 1-2 views47$13$37
Routine electrocardiogram (ecg) using at least 12 leads with tracing46$4$21
Kidney function blood test panel44$9$30
Ultrasound study of arm or leg veins with compression and maneuvers43$73$207
CT scan of abdomen and pelvis with contrast42$118$315
Hospital follow-up visit, high complexity42$96$266
Ct scan of blood vessels of chest with contrast38$101$255
Rheumatoid factor analysis38$6$20
Ct scan of soft tissue of neck without contrast37$57$140
Ct scan of cranial cavity without contrast36$52$155
Ct scan of chest with contrast36$52$167
Calcium level, total35$5$18
X-ray of ribs on side of body, minimum of 3 views34$16$44
Thyroid hormone, t3 measurement, total34$14$49
Liver function blood test panel33$8$29
Complete ultrasound of abdomen and pelvis artery and vein blood flow32$100$279
X-ray of wrist, minimum of 3 views31$14$46
Ct scan of abdomen and pelvis before and after contrast30$127$358
Phosphate level test30$4$17
Blood potassium level30$5$16
Ct scan of soft tissue of neck with contrast28$72$181
Lipase (fat enzyme) level28$7$24
X-ray of middle spine, 2 views27$11$33
Blood creatinine level27$5$18
Urea nitrogen level to assess kidney function, quantitative27$4$14
Amylase (enzyme) level24$6$23
Electrocardiogram (EKG), 12-lead24$11$43
Ct scan of upper spine without contrast21$47$138
Dxa bone density measurement of forearm, finger, hand, or foot21$31$77
Ultrasound of leg arteries or artery grafts21$79$250
Bone density scan (DEXA)19$37$101
Blood glucose (sugar) tolerance test, 3 specimens18$13$45
Initial hospital admission, high complexity18$132$517
Stool analysis for blood, by fecal hemoglobin determination by immunoassay17$16$55
Blood glucose (sugar) level13$4$14
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,211
Total received (2018-2024)
Avg $1,316/year across 7 years
Top 32% in FL for endocrinology
57
Companies
550
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,211 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,317
2023
$1,691
2022
$1,542
2021
$1,656
2020
$896
2019
$978
2018
$1,131

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$792
Amgen Inc.
$669
SANOFI-AVENTIS U.S. LLC
$624
Boehringer Ingelheim Pharmaceuticals, Inc.
$535
Xeris Pharmaceuticals, Inc.
$445
Medtronic, Inc.
$441
Janssen Pharmaceuticals, Inc
$420
Lilly USA, LLC
$397
Insulet Corporation
$396
Radius Health, Inc.
$342
Dexcom, Inc.
$319
Abbott Laboratories
$291
Amneal Pharmaceuticals LLC
$291
Amarin Pharma Inc.
$266
Esperion Therapeutics, Inc.
$259
MannKind Corporation
$248
IBSA Pharma Inc.
$173
Tandem Diabetes Care, Inc.
$161
AbbVie Inc.
$157
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$152
Mannkind Corporation
$139
Astellas Pharma US Inc
$128
AstraZeneca Pharmaceuticals LP
$118
Novartis Pharmaceuticals Corporation
$115
ABBVIE INC.
$105
Merck Sharp & Dohme Corporation
$100
PFIZER INC.
$90
RECORDATI_RARE_DISEASES_INC.
$81
Bayer HealthCare Pharmaceuticals Inc.
$66
Amryt Pharma Holdings Ltd
$63
DEXCOM, INC.
$61
Regeneron Healthcare Solutions, Inc.
$52
Antares Pharma, Inc.
$47
Becton, Dickinson and Company
$46
Kyowa Kirin, Inc.
$46
Bayer Healthcare Pharmaceuticals Inc.
$46
AbbVie, Inc.
$45
Shire North American Group Inc
$42
VistaPharm, Inc.
$37
Ultragenyx Pharmaceutical Inc.
$36
Ipsen Biopharmaceuticals, Inc
$33
Strongbridge US INC.
$29
Corcept Therapeutics
$27
Acerus Pharmaceuticals Corporation
$26
Horizon Therapeutics plc
$25
GRT US Holding, Inc.
$24
Averitas Pharma Inc.
$23
Acella Pharmaceuticals, LLC
$22
Ferring Pharmaceuticals Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Gemini Laboratories, LLC
$20
Ascendis Pharma Inc
$19
Clarus Therapeutics Inc.
$19
Zealand Pharma US, Inc.
$18
Medtronic MiniMed, Inc.
$18
Tolmar, Inc.
$13
Sun Pharmaceutical Industries Inc.
$11
Top 3 companies account for 22.6% of total payments
Associated products mentioned in payments ›
AFREZZA · BD Nano · CYCLOSET · Corlanor · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · ETERNA · EVENITY · EVKEEZA · EVUSHELD · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GATTEX · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INTELLIS ADAPTIVESTIM · INVOKAMET · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 770G System · Myrbetriq · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Natesto · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QUTENZA · Qutenza · RECORLEV · RIOMET ER · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · SYNJARDY · SYNTHROID · Saxenda · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · Vascepa · Veozah · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZOMACTON · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $18 per 100 Medicare services performed
Looking for a endocrinology in Melbourne?
Compare endocrinologys in the Melbourne area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
10
Per 100K population
1.6
County median income
$75,817
Nearest hospital
ORLANDO HEALTH MELBOURNE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Desai is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Desai experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Desai performed 5,520 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $9,211 from 57 companies across 550 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other endocrinologys in Melbourne?
Dr. Desai's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →